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Abstract
Incubation of ex vivo cultured mature B cells in the presence
of nitric oxide or nitric oxide-donor substances delays pro-
grammed cell death as determined by the appearance of
DNA laddering in agarose gel electrophoresis or by flow-
cytometry analysis of DNA. Nitric oxide also rescues B cells
from antigen-induced apoptosis but fails to provide a co-
stimulatory signal that converts the signal elicited by the
antigen into a proliferative response. The protective effects
of nitric oxide against programmed cell death can be repro-
duced by treatment of the cells with permeant analogues of
cyclic GMP. Regarding the mechanisms by which nitric ox-
ide prevents apoptosis in B cells, we have observed that
nitric oxide release prevents the drop in the expression of
the protooncogene bcl-2, both at the mRNA and protein
levels, suggesting the existence of an unknown pathway that
links nitric oxide signaling with Bcl-2 expression. (J. Clin.
Invest 1995. 95:1884-1890.) Key words: nitric oxide * B
cells * apoptosis * Bcl-2 * MHC-I
Introduction
Programmed cell death (PCD)' is a process through which
individual cells are deleted in the course of development or cell
turnover in many tissues ( 1, 2). In the immune system negative
selection of the B and T cell lineages is mediated by apoptosis
(3-5). Current perspectives implicate growth factors, a wide
array of cytokines and hormones, as well as the level of expres-
sion of "antiapoptotic" genes, such as bcl-2, bcl-x, or bax, as
critical factors controlling PCD (6-8).
Isolated mature splenic B cells, in contrast to isolated mature
T cells, rapidly undergo apoptosis in the absence of activation
by specific antigens or polyclonal mitogens (3-5). However,
in immature B cells, such as the lymphoma WEHI-231 cell line,
signaling through the IgM membrane receptor results in cell
growth arrest and in the initiation of a series of events character-
istic of PCD, therefore suggesting an important role of PCD in
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the deletion of autoreactive B cells (9). The same holds true
for B cell precursors derived from fetal liver or bone marrow
that require the supply of exogenous IL-3 or IL-7 for in vitro
growth, and initiate a precocious PCD after depletion of these
factors (10). The levels of Bcl-2, a protein encoded by a gene
isolated from the break point of translocations between chromo-
somes 14 and 18 that is highly expressed in various B cell
lymphomas ( 11), have been shown to be important for preven-
tion of apoptosis (7,12,13). Indeed, overexpression of bcl-2 in
B cells has a protective function against apoptosis (14-16).
However, in the case of T cells from mice carrying a bcl-2
transgene, clonal deletion persists despite the expression of high
levels of bcl-2, suggesting the existence of alternative pathways
controlling the switch from proliferation to apoptosis (17, 18).
Since little is known about the nature of the intracellular
pathways involved in the control of bcl-2 levels and finally in
prevention of PCD, we examined the role of nitric oxide as a
possible candidate for PCD modulation in ex vivo cultured B
cells. A role of nitric oxide has been proposed in physiopatho-
logical situations involving activation of the immune system,
such as in the graft versus host disease (19) or deletion of
activated macrophages (20). Nitric oxide is synthesized by ni-
tric oxide synthase, from which at least three different genes
have been identified (21, 22). The mechanism of action of
nitric oxide involves covalent modification of proteins (ADP
ribosylation and S-nitrosylation), as well as the activation of a
soluble guanylate cyclase, cyclic GMP (cGMP), as messenger
(21-23). Moreover, it has been proposed that nitric oxide may
also influence gene expression as reported for the calcium-medi-
ated transcription of early genes in neural cells, opening a new
view concerning the biological effects of this messenger (24).
Here we report that the presence of a low but sustained nitric
oxide release prevents apoptosis. This prevention appears to be
mediated by an increase in intracellular cGMP and leads to the
maintenance of significant levels of bcl-2 transcription. These
results offer new clues for the understanding of PCD and de-
scribe an alternative pathway to maintaining B cell survival as
well as to linking nitric oxide release to the maintenance of
Bcl-2 expression.
Methods
Chemicals. cGMP assay kit was from Amersham International (Little
Chalfont, UK). Agarose was from Pronadisa (Barcelona, Spain). Potas-
sium nitrosylpentachloruthenate was from Molecular Probes Inc. (Eu-
gene, OR). Goat anti-hamster IgG-POD was from CALTAG Labora-
tories (San Francisco, CA). Chemicals and biochemicals were from
Boehringer Mannheim (Mannheim, FRG), Sigma Chemical Co. (St.
Louis, MO), or Merck & Co., Inc. (West Point, PA).
Mice. 10-wk-old BALB/c (H-2d) or BIO.D2 (H-2d) mice carrying
a /K transgene (25) were bred in our colony. Expression of the
transgene was evaluated by PCR as described (25).
Preparation ofB cells. Spleens from five to eight animals were pooled
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and mechanically disrupted (1-mm metal mesh). The cell suspension
was kept in RPMI 1640 medium and filtered through a 10-pm nylon
mesh. Nonlymphoid cells were removed by centrifugation over a Ficoll-
Hypaque (Pharmacia, Uppsala, Sweden) discontinuous gradient. After
three washes with RPMI 1640 the cells were resuspended in this medium
containing 10% of batch-tested nonstimulatory FCS, 2 mM glutamine,
50 .tg/ml antibiotics, and 50 ,uM ,-mercaptoethanol. B cells were pre-
pared after treatment with anti-Thy-1 antibody plus complement (26).
To remove adherent cells, the cell suspension was incubated for 30 min
in plastic tissue culture dishes in the same medium. The purity of the
B cell population was assessed by immunofluorescence on a FACScan'
cytofluorometer (Becton Dickinson and Co., Cockeysville, MD) and
resulted in the expression of > 95% Ig' and < 1% of Thy-1.2+ cells.
The macrophage contamination in these preparations ranged from 1 to
3% as determined by CD1 lb staining. When FACSO (Becton Dickinson
and Co.) analysis was used, electronic gating of the lymphocyte popula-
tion was performed and the macrophage contamination was reduced to
< 0.1%. Cell viability was estimated according to the propidium iodide-
exclusion criteria, and was > 95%. B lymphocytes were maintained at
1 x 106 cells/ml in the above described RPMI 1640 medium.
NO sources. Nitric oxide was intracellularly generated using NO-
donors (27) or caged NO-compounds such as potassium nitrosylpen-
tachloruthenate after ultraviolet irradiation. A nitric oxide solution was
prepared in complete medium previously bubbled with helium, and the
concentration was spectrophotometrically determined by the changes in
absorbance at 401 and 411 nm of oxyhemoglobin, using an extinction
coefficient of 99,580 M -'cm-' (28).
Analysis of DNA fragmentation. Internucleosomal DNA fragmenta-
tion was analyzed following the procedure of Gonzalo et al. (29) as
follows: The cell suspension ( 1-2 ml) was centrifuged at 200 g at 40C
for 10 min, and the pellet was washed twice with ice-cold PBS. After
resuspension in 250 01 of PBS, an equal volume of 20 mM EDTA,
0.5% Triton X-100, 5 mM Tris-HCl, pH 8.0, was added. The incubation
was followed for 15 min at 4°C. Nuclei were removed by centrifugation
at 500 g for 10 min and the resulting supernatant was centrifuged at
30,000 g for 15 min. The fragmented DNA present in the soluble fraction
was precipitated with 70% ethanol plus 2 mM MgSO4, and aliquots
were treated for 1 h at 55°C with 0.3 mg/ml of proteinase K. After two
extractions with phenol/chloroform, the DNA was resuspended and
analyzed in a 2% agarose gel and stained with 0.5 jig/ml of ethidium
bromide.
Flow cytometry analysis ofB cells. After incubation with the appro-
priate ligands, cells were pelleted and resuspended in PBS containing
0.005% propidium iodide (30). Cells were analyzed in a FACScane
flow cytometer (Becton Dickinson and Co.) equipped with a 5-W argon
laser, and the forward scatter was plotted against the propidium iodide
fluorescence (30). Data are presented using the dot density plot function,
and the percentage of cells in the R3 plus R4 region is given in the
upper right corner of the plot. Sorting of R3 + R4 and RI regions was
done in a FACStar® PLUS flow cytometer (Becton Dickinson and
Co.). Cells in panel R2 correspond to death cells that have altered the
membrane permeability, and never exceeded more than 20% of the cell
population (30).
Preparation of soluble MHC class I (sMHC-I). sMHC-I was purified
from detergent-solubilized membranes from C57BL/6 lymphocytes
(26) as follows: The lymphocytes, a pool of spleen, thymus, and lymph
nodes were homogenized in S ml of 1 mM 1,4-dithioerythritol, 0.5 mM
PMSF, 120 mM NaCl, 0.5 mM EDTA, and 20 mM Hepes, pH 7.4, and
centrifuged twice for 10 min at 3,000 g. The membrane pellet was
resuspended in 1 ml of homogenization buffer containing 0.5% NP-40
and incubated for 30 min at 4°C. After centrifugation at 5,000 g for 20
min, aliquots of the supernatant were filtered through a Sephadex*
(Sigma Chemical Co.) G-25 (medium) column (20 X 0.5 cm) and
equilibrated with PBS to remove the detergent, and the emerging protein
was purified by affinity chromatography on an anti H2-Kk mAb-Sepha-
rose (Sigma Chemical Co.) column prepared using CNBr-activated
Sepharose and a commercial H2-Kk mAb (PharMingen, San Diego,
CA). The antigen was eluted with 50 mM glycine (pH 3.0) and stored
at -800C. Syngeneic sMHC-I was prepared from BALB/c lymphocytes
and processed following the same protocol.
RNA analysis. The RNA was extracted by the guanidinium isothiocya-
nate method (31). RNA (5 jig) was denatured at 650C for 15 min in
5% formaldehyde, 50% formamide, and 8% glycerol and were size-
separated by electrophoresis in a 0.9% agarose gel containing 2% form-
aldehyde. After transference of the RNA to Nytran membranes (NY
13-N; Schleicher & Schuell, Inc., Keene, NH) with lOX SSC (lOX
SSC is 1.5 M NaCl, 0.3 M sodium citrate, pH 7.4), the membranes
were prehybridized for 6 h at 420C in 50% formamide, 0.25 M NaCl,
0.1 M sodium phosphate, 7% SDS, and 0.01% of salmon sperm. An
865-bp probe (EcoRI/HindIl fragment) specific for murine bcl-2 was
labeled (27% of efficiency) with [a-32P]dCTP using the Random
Primed labeling kit (Boehringer Mannheim). A 500-bp (HindIll/XbaI
fragment) of GAPDH was used to normalize the RNA charge of the
lanes. The membranes were washed with 0.1 x SSC and 0.1% SDS at
room temperature for 10 min and twice at 50'C for 30 min, and then
exposed to x-ray film (X-OMAT, Eastman Kodak Co., Rochester, NY).
Quantitation of the films was performed by laser densitometry (Molecu-
lar Dynamics, Sunnyvale, CA).
Bcl-2 detection. The amount of Bcl-2 protein was determined using
a flow cytometry-based method (7). B cells (5 x 105) were washed
twice with PBS and stained with FITC-labeled anti-B220 mAb. After
washing twice with PBS, the cells were fixed with PBS containing 4%
paraformaldehyde at 20°C for 10 min. After two washes in PBS, the
cells were permeabilized with 50 ,ug/ml of digitonin in PBS for S min,
the process was stopped by dilution in 0.1 vol of FCS, and the cells
were kept at 4°C. Aliquots (2 x 105 cells) were extensively washed
and incubated for 1 h in PBS with a hamster mAb specific for murine
Bcl-2, or a control hamster mAb. The cells were washed and incubated
with F(ab')2 biotinylated rabbit anti-hamster IgG for 30 min at 4°C
and after staining were analyzed in a FACScans flow cytometer (Becton
Dickinson and Co.). More than 90% of the cells were permeabilized,
as assessed after the staining with propidium iodide. Alternatively, the
total levels of Bcl-2 were determined by Western blot analysis using a
goat anti-hamster IgG-POD as secondary antibody and revealing the
blot following the enhanced chemiluminescence protocol (Amersham).
Determination of cGMP. cGMP was measured in cultures supple-
mented with 0.5 mM isobutyl-l-methylxanthine to favor the accumula-
tion of this messenger. B cells were stimulated for 2 h, and, after washing
with PBS, the cell pellets were resuspended in 0.2 ml of an ice-cold
mixture of ethanol:water (2:1, vol:vol). After thorough mixing and
centrifugation in an Eppendorf centrifuge (Brinkmann Instruments, Inc.,
Westbury, NY), samples were speed vacuum-dried and cGMP was
measured using a specific binding kit, following the recommendation
of the supplier (Amersham).
[3H]Thymidine incorporation. Proliferation was determined by cul-
turing 105 cells per well in 96-well plates. 1 pCi of [3H]thymidine was
added for the last 15-h period of culture (72-h period). The thymidine
incorporation was measured by scintillation counting. Results are ex-
pressed as the mean disintegrations per minute incorporation of triplicate
wells.
Results
Nitric oxide release delays PCD in B cells. Ex vivo isolated
purified splenic B cells, when kept unstimulated, suffered a
progressive time-dependent degradation of DNA that was fol-
lowed by the appearance of a DNA fragmentation pattern ob-
served by agarose gel electrophoresis (Fig. 1 A, - lanes). How-
ever, when cells were incubated in the presence of substances
that produced a continuous release of nitric oxide (27), such
as 3-morpholinosydnonimine (SIN-1), a clear delay in the ap-
pearance of the apoptotic ladder pattern was observed (Fig. 1
A, + lanes).
Furthermore, an in vivo quantitative analysis of the fraction
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Figure 1. Effect of NO-donors on the apoptosis of ex
vivo cultured B cells. (A) Cells (1 x 106) were incu-
bated for the indicated periods of time in the absence
(- lanes) or with 1 ILM SIN-1 (+ lanes), and the
fragmented extranuclear DNA was analyzed by agarose
gel electrophoresis. (B) Alternatively, cells were incu-
bated for 6 h in the absence (upper panel) or in the
presence of 1 ILM SIN-I (lower panel) and analyzed
by flow cytometry. The same number of cells from the
nonapoptotic (gate RI) and the apoptotic population
(gates R3 + R4) were sorted. (C) The extranuclear
DNA was analyzed by agarose gel electrophoresis. The
results show a representative experiment out of three.
of cells displaying degradation ofDNA was followed by specific
changes in the DNA fluorescence when the cells were stained
with propidium iodide and analyzed by flow cytometry. As
shown in Fig. 1 B, after 6 h of culture, up to 77% of the B cells
from the untreated population displayed a typical pattern of
apoptosis (R3 plus R4) frequency that decreased to 19% in the
presence of SIN-1. To further ensure that the apoptotic B cell
population identified by flow cytometry effectively corres-
ponded to cells with internucleosomal DNA fragmentation, the
populations discriminated in Fig. 1 B were separated by sorting
and analyzed by agarose gel electrophoresis (Fig. 1 C). The
subpopulation selected in gates R3 + R4 is the only one under-
going DNA fragmentation when compared to the R1 population.
This protective effect of SIN-1 was also achieved by isosorbide
dinitrate, another NO-donor, as well as by repetitive priming
of the incubation with a fresh solution of nitric oxide in RPMI
1640-Hepes medium depleted of oxygen (the initial concentra-
tion of nitric oxide in this solution was 1 1tM). The endogenous
NO production in the culture was negligible and below the nM
range after 6 h of culture. In agreement with the absence of
endogenous NO release, the presence of 0.5 mM nitromethylar-
ginine (a nitric oxide synthase inhibitor) in the incubation me-
dium did not alter the apoptotic profile of B cells (not shown).
The protective effect of SIN-1 against PCD was dose dependent,
and the optimal concentration was 1 buM (Table I). As a control,
rescue of B cells from PCD by stimulation with either LPS or
surface immunoglobulin mAb plus IL-4 decreased the percent-
age of cells in the R3 + R4 panels (Table I).
Nitric oxide prevents sMHC-I-induced apoptosis in B cells.
We have recently described a system where B cells expressing
a surface immunoglobulin specific for the H-2kk haplotype of
MHC-I, when stimulated with MHC-I alloantigen H-2Kk, initi-
ate a rapid signaling process that results in apoptosis, an effect
that is prevented by some costimulatory signals, among them
those involving protein kinase C activation (26). In the present
study we tested the role of NO-donors in this system to validate
its protective role against PCD as a positive costimulatory signal
in a model of antigen-induced PCD. As shown in Fig. 2 A,
incubation of B cells for 2 h with sMHC-I produced an intense
DNA laddering that was significantly prevented when SIN-1
was present. Cells treated in this way exhibited a flow cytomet-
ric profile reminiscent of that shared by recently isolated B cells
(39% of apoptotic cells in the absence vs 9% in the presence
of SIN-i). As a control in the experiment, incubation of the B
cells with low doses of phorbol 12,13-dibutyrate (PDBu; 2 ng/
ml) before stimulation with sMHC-I prevented PCD (Fig. 2
B), converting the apoptotic signal into a proliferative response
and suggesting the relevance of costimulation (via protein ki-
nase C in this particular case) on the activation pathway (Ta-
ble II).
Nitric oxide rescue ofB cellsfrom PCD is mediated through
an increase in cGMP. Incubation ofB cells with several concen-
trations of a permeant cGMP analogue exhibited a protective
effect on the apoptosis detected in recently explanted B cells
as well as in B cells stimulated by sMHC-I (Fig. 2 B). Accord-
ingly, to ensure that cGMP was involved in the mechanism
of action of nitric oxide in B lymphocytes, experiments were
undertaken in which cGMP was measured after stimulation of
B cells. As Fig. 3 shows, incubation of B lymphocytes for 2 h
in the presence of SIN-I produced a 7.2-fold increase in cGMP.
The same result was obtained with sodium nitroprusside, a
caged NO-releasing compound. As a control, a fresh solution
of nitric oxide (1 ktM final concentration) was added to deter-
mine the maximal activation of guanylate cyclase in these cells.
Having shown that nitric oxide release in B cells involves
Table I. Flow Cytometry Analysis ofApoptotic B Cells
Percentage of apoptotic cells
Treatment Experiment 1 Experiment 2
None 65 77
SIN-1 (0.1 AM) 39 42
SIN-I (1 AM) 20 19
SIN-1 (10 jM) 19 19
SIN-1 (100 AM) 28 31
Isosorbide dinitrate (1 AM) 24 26
Nitric oxide* (1 AM) 18 25
LPS (25 Ag/ml) 17 19
sIg-mAb (5 Ag/ml) + IL-4 (2 ng/ml) 19 21
B cells were incubated for 6 h with the indicated ligands, and, after in
vivo labeling with propidium iodide, were analyzed by flow cytometry.
The percentage of cells in the R3 + R4 gates was determined as repre-
sentative of the apoptotic population. Results show the values of two
different experiments. * A fresh solution of nitric oxide was added to
the cell incubation at intervals of 1 h.
1886 A. M. Genaro, S. Hortelano, A. Alvarez, C. Martinez-A., and L Boscd
Downloaded from http://www.jci.org on May 30, 2016.   http://dx.doi.org/10.1172/JCI117869
A
Addition
sMHC-I, ng/ml
SIN
B
0 0
OO
_ _
_-
. V_
- - + + + sMHC-I
+--+- cGMP
- + -- + PDBu
Figure 2. Induction of apoptosis by sMHC-I in B cells
from transgenic mice specific for MHC class I is pre-
vented by NO-donors and phorbol esters. B cells from
mice carrying a jJK transgene were purified as pre-
viously described (see Fig. 1). The cells were incu-
bated for 2 h with 1 pM SIN-1 (A), or 100 ng/ml of
purified sMHC-I, 10 nM dibutyryl-cGMP, and 2 ng/
ml PDBu (B). The figure shows a representative ex-
periment out of three in which the same cell prepara-
tion has been incubated with the indicated ligands.
the activation of guanylate cyclase, we further determined that
cGMP mediated the protective effect of nitric oxide against
PCD using flow cytometry. As Fig. 4 shows, incubation of the
cells for 4 h with 10 nM cGMP provoked a decrease in the
spontaneous and antigen-induced PCD of B cells from 67 to
21% and from 32 to 12%, respectively.
A more extensive characterization of the mechanism of action
of NO-donors and PDBu in preventing apoptosis was under-
taken. While in the short period of time (< 12 h) both agents
worked equally well in B cell rescue from PCD, only PDBu
was able to costimulate a significant proliferative response upon
sMHC-I stimulation (Table H). These results suggested that
NO-donors as well as permeant cGMP analogues may require
still another cooperative signal to allow the B cells to progress
through the cell cycle.
Nitric oxide release sustains bcl-2 levels in B cells. One
candidate for prevention of PCD, at least in B cells, is the
expression of sustained levels of Bcl-1 (14-16). To study
Table II. Proliferative Response ofB Cells Stimulated with Nitric
Oxide-donors and Phorbol Esters
Addition Disintegrations per minute per well
None 7,968±673
sMHC-l (100 ng/ml) 3,494±345
+ SIN-I (1 AM) 1,621±274
+ cGMP (10 nM) 2,956±318
+ PDBu (2 ng/ml) 18,543±1,042
LPS (25 Mg/ml) 171,960±8,937
+ SIN-I (1 jM) 150,603±10,240
+ cGMP (10 nM) 143,826± 11,356
+ PDBu (2 ng/ml) 257,940±17,627
Proliferation was determined by culturing purified B cells from PIK
mice (10 cells per well in 96-well plates) with the indicated additions.
1 pCi of [3H]thymidine was added for the last 18 h of culture. The
thymidine incorporation was measured by scintillation counting after
retention over glass fiber filters of the acid-insoluble macromolecular
fraction. The maximal proliferative response was obtained at day 3 of
culture. A control proliferation with LPS was used to establish the
relative efficiency of the different combinations of factors used. Results
are expressed as the mean disintegrations per minute ±SEM incorpora-
tion of triplicate wells.
whether this situation also applies to B cells incubated with
nitric oxide-releasing compounds, we determined the levels of
bcl-2 mRNA and protein in B cells derived from pK transgenic
mice incubated with sMHC-I in the presence of several ligands
known to modulate the response to sMHC-I alloantigen. As Fig.
5 shows, exposure of B cells from pK transgenic mice to
sMHC-I elicited a drastic drop in the bcl-2 RNA level, an effect
that was partially antagonized by SIN-1 and PDBu but not by
the inactive phorbol ester a-phorboldidecanoate. Indeed, in the
presence of SIN-I (or PDBu), the bcl-2 RNA levels were at
least three- to fourfold higher than those from unstimulated
cells, reinforcing the view that nitric oxide release was sufficient
to maintain the bcl-2 RNA levels. Moreover, when the Bcl-2
protein content was measured in situ in permeabilized B220+
cells using flow cell cytometry, a clear protective effect of SIN-
1 was observed over the sMHC-I-induced drop in Bcl-2 (Fig.
6 A). Whereas the mean of the fluorescence distribution corre-
sponding to Bc1-2 content decreased from 15 to 7 upon stimula-
tion with sMHC-I, in the presence of SIN-1 the corresponding
value was 12. Finally, the total amount of Bcl-2 was also mea-
sured by Western blot analysis, and, in agreement with data
decribed above, the levels of Bcl-2 were enhanced after addition
of SIN-I or a permeant cGMP analogue -(Fig. 6 B).
Discussion
Maturation of B cells from their progenitors in the bone marrow
is mainly controlled by cytokines, the temporal pattern of anti-
cGMP, pmol/mg of protein
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Figure 3. Intracellular
cGMP levels in B cells
treated with NO-donors.
B cells (106) were incu-
bated for 2 h with the in-
dicated concentration of
nitric oxide or NO-do-
nors. cGMP was assayed
using a commercial kit.
Results show the
mean±SEM of three in-
dependent preparations
of B cells.
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gen recognition, and specific cellular interactions; through all
of these, the deletion or functional anergy of the precursor popu-
lation occurs (32-33). Therefore, the control of the apoptotic
process plays a selective role in the course of B cell maturation
(32-34).
The identification of the mechanisms involved in B cell sur-
vival through the different stages of proliferation and differenti-
ation of the precursors is of interest for the understanding of B
cell biology. For this reason, attention has been devoted to the
identification of signaling pathways involved in these processes.
The protective effect exerted through CD40 signaling in the
blockage of the apoptosis in B cells induced after antigen recep-
tor cross-linking is a good example (35). CD40 in humans is
expressed in both pre-B cells and mature B cells, and activation
through this molecule prevents apoptosis not only in circulating
B cells but also in immature B cell lines such as WEHI-231
cells (34, 35). CD40 is closely related to the TNF-a receptor,
whereas its natural ligand (CD40L) is structurally related to
the family of TNF-a molecules. CD40L is expressed in the cell
surface of activated T cells but not in resting T cells, therefore
providing costimulatory signals in the process of B cell-T cell
interaction (34, 35). TNF is an inducer of nitric oxide release
in different cell lines, among which are those of lymphoid origin
(36, 37). We thus considered the possibility that nitric oxide
was one of these early molecules (second messengers) that
participated in the control of PCD. Nitric oxide is a gaseous
molecule released by different cells in response to activation
by cytokines (IFN-y, TNF-a), growth factors, and bacterial
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endotoxins (21, 36-38). Moreover, due to its chemical nature,
nitric oxide may easily cross the cell membrane, acting both as
an intra- and intercellular messenger, and for this reason it may
play a role both in the germinal centers and in the process of
recognition of circulating B cells by activated T cells.
The protective role of nitric oxide against PCD in B cells
contrasts with the NO-dependent induction of apoptosis ob-
served in other cell types such as macrophages (20), which
suggests the existence of cell-specific pathways in the response
to nitric oxide. This opposite response to nitric oxide in B
cells and macrophages is not unique since neuroprotective and
neurodestructive effects of nitric oxide have been reported in
neurons; this complex behavior has been explained on the basis
of the different redox states of nitric oxide once released in the
cytoplasm of the cell (39, 40). Moreover, it is also possible
that the involvement of other signaling molecules can influence
the regulation of the expression of the inducible form of nitric
oxide synthase as reported for the complex dual stimulation of
macrophages with traces of LPS and IFN-y (41).
Regarding bcl-2, recent reports propose that the expression
of this protoocogene has a protective role against oxidative
stress, involving in neural tissues an increase in the intracellular
concentration of glutathione (40). In agreement with these re-
ports, overexpression of bcl-2 in neural cell lines prevents PCD
by decreasing the generation of reactive oxygen species (40),
a situation that does not apply for B cells (42). Our finding
that nitric oxide maintains the bcl-2 levels both in unstimulated
and sMHC-I-activated mature B cells offers a possible explana-
tion for the antiapoptotic effect of nitric oxide in this particular
system. Moreover, because Bcl-2 is a long-lived protein under
normal conditions, the fall in Bcl-2 content after sMHC-I stimu-
lation indicates that an active Bcl-2 degradation occurs under
these conditions, and it suggests the existence of multiple path-
ways in the control of Bcl-2 degradation. This decrease in Bcl-2
content in cells displaying DNA degradation has been confirmed
both by an in situ flow cytometry assay in permeabilized cells
and after quantification of the total Bcl-2 content by Western
blot analysis.
Expression of bcl-2 has been shown to be highly regulated
along development of B lymphocytes. For instance, susceptibil-
ity to dexamethasone-induced PCD depends on the stage of B
cell maturation and correlates well with the amount of bcl-2
expressed by individual cells (7). The mechanism by which
nitric oxide prevents the drop in bcl-2 mRNA levels is yet
V ',.J Figure 5. bc1-2 mRNA levels are maintained in splenic B
cells incubated with NO-donors. (Left) B cells from /IdK
transgenic mice were incubated for 6 h in the absence (lane
1) or in the presence of 100 ng/ml sMHC-I (lanes 2-5),
and I1M SIN-i (lane 3) or 2 ng/ml of a-phorboldideca-
2 3 4 5 noate or P-PDBu (lanes 4 and 5). (Right) After densitome-
try, the ratio of intensities corresponding to the bc1-2 and
lane GAPDH were expressed in arbitrary units.
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Figure 6. NO-donors maintain Bcl-2 levels in sMHC-I-stimulated cells.
(A) B cells from PK transgenic mice were incubated for 6 h in the
absence (traces a-c) or in the presence of 100 ng/ml of sMHC-I (traces
d and e) and with 1 /.M of SIN-I (traces c and e). Results show the
flow cytometry profile in B220 positive cells for the content in Bcl-2,
including a control hamster antibody (trace a). The mean fluorescence
of the distribution is given in the upper quadrant of each plot. The figure
shows a representative experiment out of three. (B) Alternatively, total
BcI-2 content (10' cells) was determined by Western blot analysis in
cells incubated for 6 h in the absence (lane 1) or presence (lanes 2-
4) of 100 ng/ml of sMHC-I and 1 uM SIN-i (lane 3) or 20 nM
dibutyryl cGMP (lane 4). Lane 5 corresponds to a control incubated in
the presence of 1 MM SIN-1. The band intensity was expressed as
percentage respect to the content of lane 1.
unknown, but a few cases in which gene expression is modu-
lated by nitric oxide as occurs in the amplification by nitric
oxide of the calcium-dependent transcription of early genes in
neuronal cells have been described (24).
The complex regulation of apoptosis and cell survival in-
volves particular combinations of signals leading to pathways
that are not always identified. Therefore, it is conceivable that
PCD-inhibitory compounds can be used to counteract the in-
creased apoptotic decay of lymphocytes, for instance, triggering
after viral infection (43). Moreover, these compounds may ex-
ert immunostimulatory effects by impeding the deletion and/or
increasing the longevity of stimulated lymphocytes. The results
here presented describe a new, useful pathway to prevent
apoptosis of B cells, and may provide new insights into the link
between the interactions at the membrane surface levels and
the distal events that control B cell apoptosis or progression
through the division cell cycle and terminal differentiation of
B cells (44).
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